Introduction: From Courtroom Battles to Balance Sheet Assets In the high-stakes arena of the pharmaceutical industry, intellectual property is the […]

Section 1: The Patent as the Central Economic Engine In the pharmaceutical industry, intellectual property (IP) is not merely an

Introduction: The High-Stakes Game of Time In pharmaceuticals time is the most valuable currency. It represents the years of painstaking

The path from a promising molecule to a life-changing medicine is longer, more expensive, and more fraught with peril than

The transition of a pharmaceutical product from a patent-protected brand-name drug to a competitive generic is a cornerstone of modern

In pharmaceutical development, where a single patent can underpin a franchise worth tens of billions of dollars, the concept of

This report is designed for the strategic executive and the savvy in-house counsel. It’s a guide to moving beyond the

In the pharmaceutical industry value is created not just in the laboratory but on the complex chessboard of international trade

Let’s be candid. The era of the single-modality blockbuster, the “one-pill-fits-all” small molecule or the “one-target” monoclonal antibody, is drawing